CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

ADMA BIOLOGICS, INC.

ADMA
$2.14BMid Cap

Next catalyst

No upcoming catalyst in our data

No upcoming FDA decision, filing or trial readout is on file for ADMA. That does not mean none is planned.

Get an email about ADMA's next catalysts

Track ADMA BIOLOGICS (ADMA) and we email you when an FDA date moves, 7 days and 1 day before the decision when the exact day is known, and when it is announced. Free account, no card.

Catalyst Timeline

0 upcoming, 1 past

No catalysts found.

Market Overview

Stock performance and key metrics

NASDAQBiological Products, (No Diagnostic Substances)πŸ‡ΊπŸ‡ΈNorth AmericaRAMSEY
Drug Pipeline

Frequently asked questions

What is in ADMA BIOLOGICS, INC.'s drug pipeline?β†’

CatalystAlert tracks 3 drug candidates in ADMA BIOLOGICS, INC.'s (ADMA) pipeline across Phase 3, Phase 2. Its lead program is Nabi-IGIV [Immune Globulin Intravenous (Human). ] (Phase 3). Each drug's phase, indication and upcoming catalysts are listed on this page.

When is ADMA BIOLOGICS, INC.'s next FDA catalyst?β†’

CatalystAlert tracks every upcoming catalyst for ADMA BIOLOGICS, INC. (ADMA) β€” PDUFA decision dates, Phase 1/2/3 trial readouts, FDA advisory committee meetings and NDA/BLA filings β€” each confidence-rated as confirmed, estimated or AI-detected.

How do I track ADMA biotech catalysts?β†’

Add ADMA to your CatalystAlert watchlist for alerts ahead of each catalyst, and follow ADMA BIOLOGICS, INC.'s live catalyst calendar, drug pipeline and clinical-trial timeline on this page β€” sourced from ClinicalTrials.gov, FDA and SEC filings.

Data is aggregated from public sources (FDA, SEC, ClinicalTrials.gov). While we strive for accuracy, information may be incomplete, delayed, or contain errors. Terms apply